Evolv Technologies Holdings, Inc. provided earnings guidance for the year 2022. For the year, the company expected total revenue to be in the range of $29 million to $31 million. Operating loss to be $82 million to $84 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.87 USD | +1.41% | +3.99% | -39.19% |
May. 22 | Lee Health Selects Evolv Technology For Weapons Detection | CI |
May. 10 | Evolv Technology Shares Plunge After Full-Year Revenue Guidance Cut | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.19% | 442M | |
-6.13% | 41.96B | |
-4.95% | 10.72B | |
-10.79% | 7.56B | |
+4.69% | 6.51B | |
+14.13% | 3.18B | |
+8.70% | 2.3B | |
+51.12% | 1.85B | |
+8.12% | 1.74B | |
+2.17% | 1.51B |
- Stock Market
- Equities
- EVLV Stock
- News Evolv Technologies Holdings, Inc.
- Evolv Technologies Holdings, Inc. Provides Earnings Guidance for the Year 2022